PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

48,663 stories, page 53 of 812

Advanced search
🌍discoverynews.google.comTier 3 · Aggregated media

Biotechs buck a sluggish IPO market, but investors should tread warily

CNBCOriginal source
🌍Mediaskpharmteco.comTier 3 · Secondary coverage

SKyvec™ Lenti for In Vivo Fact Sheet

SkpharmtecoOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Genmab Stock (GMAB) Soars Over 30% on Strong Phase 3 Results for the Company’s Head and Neck Cancer Treatment

TipRanksOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Hot-melt extrusion in pharmaceutical implant manufacturing

News-MedicalOriginal source
🇧🇷Researchufrj.brTier 2 · Direct publisher

Emerência coletiva homenageia seis docentes da Faculdade de Letras

UFRJ BrazilOriginal source
🌍Industryapple.comTier 1 · Company source

Apple unveils groundbreaking MacBook Pro with PROLED XDR Display

Apple Health NewsroomOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

CSPC Pharmaceutical Group (SEHK:1093) Stock May Be 44% Undervalued On RSV Trial Start

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

RFK Jr. to Allow Broad Use of Unapproved Peptide Injections

The New York TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

C4IP Urges Treasury to Reconsider Proposed Rule to Extend COINS Act Investment Restrictions to Biotech

IPWatchdogOriginal source
🇺🇸Industrycertara.comTier 1 · Company source

What is new in Phoenix 8.9?

CertaraOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

3 ESMO 2026 Results in Endometrial and Breast Cancer to Know

Cure TodayOriginal source
🇺🇸Industryyprime.comTier 1 · Company source

IRT Masking Global Ophthalmology Study

YPrimeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Here's How The FDA's Temporary Peptide Compounding Policy Impacts Access, Costs And Safety

Blavity NewsOriginal source
🇧🇷Researchufrj.brTier 2 · Direct publisher

Nova direção no Instituto de Ciências Farmacêuticas e no Instituto de Alimentação e Nutrição do CM/UFRJ-Macaé

UFRJ BrazilOriginal source
🌍Industrydarebioscience.comTier 1 · Company source

Press Release: Daré Bioscience Addresses New National Focus on Women’s Health in Virtual Investor “What This Means” Discussion

Dare BioscienceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Geron Corporation Provides Update on Phase 3 IMpactMF Clinical Trial of Imetelstat in Relapsed/Refractory Myelofibrosis

marketscreener.comOriginal source
🇮🇹Researchhumanitas.itTier 2 · Direct publisher

Ictus: i primi sintomi e cosa fare

Humanitas Research HospitalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Abu Dhabi and Novartis activate Clinical Trials Hub through global Phase 3 programmes

BioSpectrum AsiaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

First patient dosed in phase 3 NPI-001 trial for Usher syndrome RP | Eye Care Network - Modern Retina

Ophthalmology TimesOriginal source
🌍Industryexozymes.comTier 1 · Company source

Benzinga: The Next Industrial Revolution May Come From Biology

eXoZymesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA scientists opposed the Trump administration's effort to ease peptides access

ABC News - Breaking News, Latest News and VideosOriginal source
🇺🇰Researchnews.cancerresearchuk.orgTier 2 · Direct publisher

Latest winner in our Research is Beautiful competition

Cancer Research UKOriginal source
🌍Industryscripps.orgTier 1 · Company source

10News Interview Explores Brain’s Far-Reaching Impact on Health

Scripps HealthOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

How Waters wants AI to take the grunt work out of drug testing

FortuneOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA identifies nine drugs that pose risks to driving

Taipei TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Portland biotech startup lands $1.2 million grant, aims to make protein research faster, cheaper using AI

OregonLive.comOriginal source
🌍Researchnews.uci.eduTier 2 · Direct publisher

UC Irvine's Paul Merage School of Business hosts the "Future of Transportation"

University of California IrvineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

SELLAS Life Sciences Stock (SLS) Slides 18% as a Phase 3 Study Enters Its Evaluation Period

TipRanksOriginal source
🇪🇸Regulatoryaemps.gob.esTier 1 · Regulatory source

La AEMPS informa de la retirada y recuperación del lote 20250620 del cosmético Smilekit Teeth Whitening pen

AEMPS (Spain)Original source
🇩🇪Researchuni-freiburg.deTier 2 · Direct publisher

Websites and services are now available

University of FreiburgOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Anthropic Bought Mithril, a One-Man Biotech Startup Built by an Anonymous X User

The Profile | Polina PomplianoOriginal source
🌍Regulatoryima.isTier 1 · Regulatory source

We say goodbye to ima.is

IMA IcelandOriginal source
🌍Regulatoryifpma.orgTier 1 · Regulatory source

76th WHO Regional Committee for Europe: Matters arising from Resolutions and Decisions of the World Health Assembly

IFPMA GlobalOriginal source
🌍Associationnephsap.orgTier 3 · Secondary coverage

New nephSAP Issue: Chronic Kidney Disease

American Society of NephrologyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Acumen Pharmaceuticals: A Speculative Buy Ahead Of November's Alzheimer's Readout

Seeking AlphaOriginal source
🇺🇰Regulatoryabpi.org.ukTier 1 · Regulatory source

Pharmaceutical industry backs Budget move to lift VAT barrier on free-of-charge medicines

ABPI UKOriginal source
🇨🇭CROpsi-cro.comTier 2 · Direct publisher

Appian and PSI CRO Form Strategic Partnership to Advance AI-driven Clinical Trial Operations

PSI CROOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Avian influenza: guidance, data and analysis

The symptoms, diagnosis, management and epidemiology of avian influenza (bird flu).

UK Health Security AgencyOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Avian influenza: managing human exposures and sporadic cases

Guidance for the management of individuals exposed to avian influenza, and sporadic human cases and...

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

California biotech lays off nearly all its staff after drug trial failure and 2 patient deaths

SiliconValley.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Repligen Corporation (RGEN) Benefits From Biotech Momentum and Strong Earnings

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Caravel Bio lands $1.2M NSF grant, hires CTO

The Business JournalsOriginal source
🇯🇵Industrynippon-shinyaku.co.jpTier 1 · Company source

第18回 日本新薬こども文学賞 表彰式を開催

Nippon Shinyaku NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pharma Meets Digital Health: Who Owns Data Standards and Security?

healthcare-in-europe.comOriginal source
🇺🇸CDMOcookmedical.comTier 2 · Direct publisher

Cook Medical launches Neurodiversity & Disability Business Resource Group

Cook PharmicaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AAPS PharmSci 360 2026: CMC and NAM Strategies

PharmTech.comOriginal source
🌍Researchjournals.plos.orgTier 2 · Direct publisher

Alzheimer’s disease research must connect vascular molecular phenotypes with physiology

PLOS Biology RSSOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Lilly’s triple-G drug beats Ozempic in head-to-head study

STATOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Amgen hit with FDA warning letter for ‘misleading’ Vectibix promotion

Fierce PharmaOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Anthropic plots IPO amid ongoing foray into drug development

Pharmaceutical TechnologyOriginal source
🇩🇪Researchklinikum.uni-heidelberg.deTier 2 · Direct publisher

Informationstag: Leistenbruch, Nabelbruch, Narbenbruch – wann ist eine Operation notwendig?

Universitätsklinikum HeidelbergOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

LipoTrue to Launch Three New Biotech Actives at in-cosmetics Asia

Cosmetics & ToiletriesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Qingdao Vland Biotech INC. Reports Earnings Results for the Nine Months Ended September 30, 2026

www.marketscreener.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ChatGPT Linked to Death; FDA Flags Cancer Drug Claims; AMA Fights Medicaid Rules

MedPage TodayOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Zhejiang Orient Gene Biotech Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2026

www.marketscreener.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

A Case Study in Developing the Next Generation of Biotech Skincare: Q&A with Dermalogica, Core Biogenesis

Cosmetics & ToiletriesOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Field Safety Notices: 19 to 23 October 2026

MHRA UKOriginal source
🇫🇮Researchhelsinki.fiTier 2 · Direct publisher

Lähes joka kolmannella urheilijalla on kohonnut LDL-kolesteroli

Helsinki University ResearchOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Endometrial Cancer Drug Reduced Death Risk by 32% in Phase 3 Trial

Technology NetworksOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Nacuity Pharmaceuticals Announces First Patient Dosed in Global Confirmatory Phase 3 Trial of NPI-001 (N-acetylcysteine amide) Tablets for the Treatment of Retinitis Pigmentosa Associated with Usher Syndrome

The Manila TimesOriginal source